Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Ralf Reilmann, Karen E. Anderson, Andrew Feigin, Sarah J. Tabrizi, Blair R. Leavitt, Julie C. Stout, Paola Piccini, Robin Schubert, Pippa S. Loupe, Anna Teige Wickenberg, Beth Borowsky, Gail Rynkowski, Rita Volkinshtein, Thomas Li, Juha‐Matti Savola, Michael R. Hayden, Mark Forrest Gordon, Mark Guttman, Lynn A. Raymond, Tilak Mendis, Oksana Suchowersky, Jody Corey‐Bloom, Michael D. Geschwind, Frederick J. Marshall, Karen Marder, Martha Nance, Brad A. Racette, Jee Bang, Victoria Segro, Katherine E. McDonell, John Kamholz, Mark S. LeDoux, Juan Sanchez‐Ramos, Giuseppe Demichele, Caterina Mariotti, Ferdinando Squitieri, Paola Soliveri, Pietro Cortelli, José Esteban Muñoz García, J. Kulisevsky Bojarski, José Luis López-Sendón, Koldo Berganzo Corrales, Esther Cubo, José Manuel García Moreno, Michael Orth, Josef Priller, Carsten Saft, A. Weindl, Juergen Winkler, David Craufurd, Z Miedzybrodzka, Hugh Rickards, Rhys Richard Davies, Nayana Lahiri, Deborah Ruddy, Suresh K Komati, Oliver William John Quarrell, Leonor Correira Guedes, Raymund A.C. Roos, Zuleykha Zalyalova, С. Н. Иллариошкин, А В Густов, Jiří Klempíř